Global Polio Vaccine Market Size By Polio Vaccine Type, By Application, By Geographic Scope And Forecast

Polio Vaccine Market Size And Forecast

Polio Vaccine Market size is valued at USD 699.5 Million in the year 2024 and is projected to reach USD 1067.81 Million in 2031, growing at a CAGR of 4.6% from 2024 to 2031.

Global Polio Vaccine Market Drivers

The market drivers for the Polio Vaccine Market can be influenced by various factors. These may include

• Government Initiatives and Vaccination Programmes In an effort to end polio, numerous nations have started massive vaccination campaigns in cooperation with international agencies like UNICEF and the World Health Organisation (WHO). The need for polio vaccines is greatly fueled by these initiatives.
• Growing Polio Incidence in Some Areas In spite of international efforts, polio outbreaks continue to happen, especially in some areas of Asia and Africa. Vaccination efforts are stepped up in response to these outbreaks in an attempt to contain and stop the disease’s spread.
• Technological Developments in Vaccines New developments in vaccine technology, such as the creation of safer and more effective vaccinations, support market expansion. Novel delivery methods and improved vaccine formulations are examples of advances that increase immunisation uptake and efficacy.
• Growing Knowledge and Healthcare Spending The market is supported by growing knowledge of the value of vaccinations as well as growing healthcare spending in many nations. The demand for vaccines is rising as governments and non-governmental organisations invest more in healthcare facilities and immunisation programmes.
• Global Polio Eradication Initiatives By providing money and assistance for vaccination programmes worldwide, organisations such as the Global Polio Eradication Initiative (GPEI) are crucial in propelling the market. Their work is essential to keeping a high immunisation rate and tracking polio outbreaks.
• Rising Birth Rates in Developing Nations A greater target population for polio vaccination is produced by rising birth rates in developing nations. The ongoing need for polio immunisations is influenced by this demographic aspect.
• Partnerships and Collaborations Governments, non-governmental organisations (NGOs), and businesses in the private sector work together to improve the efficacy and reach of polio vaccine campaigns, which propels market expansion.
• Economic Gains from Polio Eradication Governments and organisations are encouraged to invest in vaccination programmes by the financial gains from polio eradication, which include lower healthcare expenses and increased productivity. This increases demand in the market.
• Regulatory Support and Approvals The expansion of the industry is facilitated by favourable regulatory frameworks and expedited FDA and EMA approvals for novel vaccines. The timely distribution and availability of vaccines is guaranteed by regulatory support.

Global Polio Vaccine Market Restraints

Several factors can act as restraints or challenges for the Polio Vaccine Market . These may include

• Manufacturing Difficulties Strict quality control and biosafety procedures are needed during the production of polio vaccines. Shortages of supplies can result from any interference with the manufacturing process, including contamination and equipment malfunctions.
• Cold Chain Logistics To preserve their effectiveness, polio vaccines, especially the oral polio vaccine (OPV), must be transported and stored at a certain temperature. Inadequate cold chain facilities can make it more difficult to distribute vaccines, particularly in low-income areas.
• Financial Restraints Governments and international organisations are frequently the source of funding for polio immunisation campaigns. The extent of immunisation efforts and the availability of vaccinations may be restricted by a lack of financing.
• Cost of Vaccination Programmes The expenses associated with putting in place extensive vaccination programmes, such as those related to staffing, logistics, and public awareness campaigns, can add up. The frequency and reach of vaccination drives might be impacted by financial limitations.
• Political Instability Because of population dislocation and security concerns, areas undergoing political unrest or violence may find it challenging to implement regular and extensive vaccination campaigns.
• Vaccine hesitation In communities, vaccine hesitation can be caused by misinformation and mistrust of vaccinations. Misconceptions and cultural beliefs regarding the effectiveness and safety of vaccinations can lower vaccination rates.
• Regulatory Approvals Getting regulatory permission for brand-new vaccines or modifications to already-approved ones may be a difficult and drawn-out procedure, which may cause a delay in the product’s release onto the market.
• Policy Variations Health policies and regulatory frameworks differ among nations, which might make it more difficult for polio vaccinations to be distributed and accepted internationally.
• Emerging Health Crises Polio vaccination campaigns may receive less attention and funding as a result of outbreaks of other diseases like COVID-19. Health systems can give priority to current risks over ongoing efforts to eradicate polio.
• Vaccine Development It can be expensive and technically difficult to create new and improved polio vaccines, such as those that offer easier administration or longer-lasting immunity.
• Innovation Stagnation The market’s ability to grow may be hampered by a lack of innovation in vaccination technology as a result of high costs and risk issues.
• Challenges associated with near-eradication As polio is almost completely eradicated, people may become less inclined to get vaccinated, which could result in a decline in vaccination rates. There is a chance that this will resurface.

Global Polio Vaccine Market Segmentation Analysis

The Global Polio Vaccine Market is Segmented on the basis of Polio Vaccine Type, Application, and Geography.

Polio Vaccine Market, By Polio Vaccine Type

• Oral Polio Vaccine (OPV)
• Inactivated Poliomyelitis Vaccine (IPV)

Based on Polio Vaccine Type, the market is bifurcated into, Oral Polio Vaccine (OPV), Inactivated Poliomyelitis Vaccine (IPV). OralPolio Vaccine is leading in the segment used in the fight to eradicate polio and it can replicate effectively in the intestine which enables an individual to mount an immune response against the virus

Polio Vaccine Market, By Application

• Public
• Private

Based on Application, the market is bifurcated into the public and private segments. The public segment is estimated to hold the largest share. Government policies and their fight to eradicate polio has been the major cause for the growth of the segment

Polio Vaccine Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

On the basis of Geography, the Global Polio Vaccine Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. Asia Pacific region is leading in the segment and holds the largest industry in the globe, as the number of polio vaccination is highest in the region. North America and Europe also hold a decent amount of share in the market

Key Players

The major players in the Polio Vaccine Market are

• Pfizer
• Sanofi, Astellas Pharma
• Serum Institute of India Pvt. Ltd.
• Haffkine Bio-Pharmaceutical Corporation Ltd.
• Panacea Biotec Ltd.
• GlaxoSmithKline (UK)
• Bharat Biotech (India)
• China National Biotec Group (China)
• Walvax Biotechnology Co., Ltd. (China)
• IMVAM (Canada)

Report Scope

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.